Key result
Preoperative interscalene lidocaine blockade fails to reduce 24-hour oxycodone consumption versus postoperative blockade.
Why the study?
There were no clinical studies investigating the pre-emptive analgesic effects of interscalene brachial plexus block for shoulder surgery.
Does pre-emptive interscalene brachial plexus blockade reduce postoperative oxycodone consumption and pain in patients undergoing elective shoulder surgery?
RCT (n=60)
Blinded (recovery and ward personnel)
Randomized
No
Does pre-emptive interscalene brachial plexus blockade reduce postoperative oxycodone consumption and pain in patients undergoing elective shoulder surgery?
Answers are grounded in this paper and cite their sources.
Pre-emptive interscalene brachial plexus blockade with lidocaine does not reduce postoperative pain or opioid consumption compared to postoperative blockade in patients undergoing shoulder surgery.
EDITOR: It has been proposed that analgesia given before a noxious stimulus prevents central sensitization and is thus more effective than the same analgesia given after the stimulus [1-3]. Several studies using local anaesthetics, opioids, non-steroidal anti-inflammatory drugs (NSAIDs) and the N-methyl-D-aspartate (NMDA) antagonist ketamine have been conducted to test the hypothesis of pre-emptive analgesia, but with contradictory results [4-6]. Although pre-emptive analgesia has been studied in association with different kinds of surgery, there appear to be no clinical studies about any pre-emptive effects of an interscalene brachial plexus block for surgery of the shoulder. After institutional approval from our Ethics Committee, we examined the pre-emptive analgesic effect of interscalene brachial plexus block in 60 patients (ASA I-II) undergoing elective surgery of the shoulder (diagnosis: rotator cuff syndrome) in a prospective, randomized manner. According to a pilot study with 20 patients in two groups, we wanted to detect more than a 30 min difference in the interval from the beginning of the blockade to the first dose of oxycodone, accepting a one-tailed α-error of 5% and a β-error of 20%. This power analysis yielded a sample size of 15-16 patients. Interscalene brachial plexus blockade with lidocaine 35 mL (10 mg mL−1) using Winnie's method was performed 30-60 min before the start of anaesthesia (Group 1) or just after the end of the operation, but before the end of general anaesthesia (Group 2). A third group (Group 3) did not receive any local anaesthesia, thus serving as an internal sensitivity control group. A standardized general anaesthetic was given to every patient comprising thiopental, succinylcholine, alcuronium bromide and enflurane in N2O/O2, 70/30%. Postoperative pain relief was facilitated using a patient-controlled analgesia (PCA) device programmed to deliver oxycodone 0.025 mg kg−1 body weight intravenously (i.v.), lockout time 8 min, maximal dose of oxycodone 0.1 mg kg−1 h−1. A loading dose of oxycodone 0.06 mg kg−1 i.v. was administered when patients first asked for pain relief in the recovery room after operation. The consumption of oxycodone during the first 6, 12, 18 and 24 h and the interval from the start of the block to the first dose of oxycodone were registered. Patients were instructed in the use of the PCA device and the visual analogue scale (VAS) before the operation, and they assessed their postoperative pain at rest using a 10 cm VAS (0 = no pain, 10 = worst pain) starting in the recovery room when the loading dose was given and at 1, 2, 3, 6, 9, 12, 15, 18, 21 and 24 h thereafter. The recovery and ward personnel were unaware to which group the patients had been allocated. All 60 patients enrolled completed the study. The patients' characteristics data of the three groups did not differ statistically (one-way ANOVA). There were no significant differences between the groups at any time point in the VAS scores (median (range) 3 (0-10) in Groups 1 and 2; 5 (1-10) in Group 3; Kruskal-Wallis ANOVA), or in cumulative oxycodone consumption (at 24 h: 62.3 ± 26.7 (SD) mg in Group 1; 51.0 ± 31.5 mg in Group 2; 67.1 ± 38.9 mg in Group 3, respectively). The time intervals from the end of the operation to the loading dose of oxycodone were 49 ± 44 min in Group 1, 119 ± 65 min in Group 2 and 23 ± 17 min in Group 3 (P < 0.02). There are no studies available with which to compare our results using a brachial plexus block for pre-emptive analgesia, but our negative results are in accordance with the majority of studies on pre- versus postsurgical wound infiltration and epidural block. In all such studies, the experimental design corresponded with the recommendations for studying pre-emptive analgesia [2], which means that both the pre- and postoperative groups received an identical regional procedure. Whether the preoperative block produces pre-emptive analgesia or not was planned to be based on the consumption of oxycodone. For this reason, the exact time - when the patient asked for pain relief for the first time and received a loading dose of oxycodone - was registered. As expected, the time interval from the end of the operation to the first request of oxycodone was shorter in patients who received no blocks at all when compared with those receiving blocks before or after surgery. The 24 h period of oxycodone consumption started approximately 70 min later after the operation in the group that received the block after the operation compared with the group which received a block preoperatively. Since 24 h is a relatively long observational period in our regional anaesthesia model employing lidocaine, this should not affect the total consumption of oxycodone. The consumption of oxycodone and pain were registered for 24 h starting from when the loading dose for pain relief was given. The VAS scores and the consumption of oxycodone were similar in every consecutive period of 6 h in all groups, which meant that the preoperative blockade did not show any pre-emptive effect for 24 h starting from when the loading dose was given. In other words, if our study had demonstrated a pre-emptive analgesic effect in the 24 h starting from when the loading dose was given, the oxycodone consumption should have been smaller in patients treated by preoperative blockade than in those treated with the postoperative block. We used regional anaesthesia together with a standardized general anaesthesia. No opioids or other analgesics that affect central pain processing were given before or during surgery. Regional analgesia lasted to the end of surgery in the majority of Group 1 patients. However, there may have been some patients in whom the sensory blockade may have disappeared before the end of surgery. This could have caused an impaired pre-emptive analgesia effect in them. Another explanation for the lack of a pre-emptive effect might be that a brachial plexus block could be insufficient to block all the sensitive central input. Birbaumer and colleagues found, using neuroelectric or neuromagnetic source imaging, substantial reorganization of the primary somatosensory cortex subsequent to amputation, and a strong relationship between the degree of cortical reorganization with phantom limb pain has been demonstrated. When upper limb phantom pain was treated by brachial plexus block, a very rapid elimination of cortical reorganization in the somatosensory cortex in most, but not in all, patients was detected [7]. Shoulder surgery was used as a pain model because it usually elicits moderate to severe postoperative pain. The postoperative regional plexus blockade was effective in abolishing the requirement of oxycodone for pain relief as long as it lasted. Because of the short duration of the preoperative interscalene plexus block, inflammation and hyperalgesia at the wound may have evoked neuronal sensitization in the early postoperative period, explaining the failure to produce a pre-emptive analgesic effect. Perhaps a preincisional block covering the immediate postoperative period, i.e. employing a long-acting local anaesthetic such as bupivacaine, is required to achieve a pre-emptive analgesic effect. K. M. Haltiavaara J. O. Laitinen S. Kaukinen Department of Anaesthesia and Intensive Care; Tampere University Hospital; Tampere, Finland T. J. Viljakka Department of Hand and Orthopaedic Surgery; Tampere University Hospital; Tampere, Finland P. J. Laippala Tiina H.
No takes yet. Share an insight, caveat, or question.
Haltiavaara et al. (2003) conducted an RCT in Elective surgery of the shoulder (rotator cuff syndrome) (n=60). Preoperative interscalene brachial plexus blockade with lidocaine vs. Postoperative blockade (Group 2) or no blockade (Group 3) was evaluated on Cumulative oxycodone consumption at 24 hours (p=NS). Preoperative interscalene brachial plexus blockade with lidocaine did not reduce 24-hour cumulative oxycodone consumption compared to postoperative blockade.
Synapse has enriched 10 related papers. Consider them for comparative context: